Studies have shown that ADRB2 can directly interact with and upregulate AKR1B1 in pancreatic cancer cells, promoting cell proliferation and inhibiting apoptosis through the ERK1/2 pathway (Xiao et al., 2018). Here, AKR1B1 is linked to familial pancreatic carcinoma.